CAS: 514814-49-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PMX 205 REF: IN-DA01B4VTCAS: 514814-49-4 | 98% | To inquire | Mon 02 Dec 24 |
 | PMX 205 REF: TM-T12506LCAS: 514814-49-4 | 98% | To inquire | Tue 03 Dec 24 |
 | PMX 205 REF: 3D-PVA81449CAS: 514814-49-4 | Min. 95% | To inquire | Mon 13 Jan 25 |
Ref: IN-DA01B4VT
| 1mg | 127.00 € | ||
| 5mg | 563.00 € | ||
| 10mg | 629.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
PMX 205
CAS:514814-49-4
PMX 205 is an effective complement antagonist of the C5a receptor.
Formula:
C45H62N10O6
Purity:
98%
Color and Shape:
Solid
Molecular weight:
839.04
Ref: TM-T12506L
| 1mg | 880.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
PMX 205
CAS:514814-49-4
PMX 205 is a peptide drug that has been shown to have multiple effects on …
Formula:
C45H62N10O6
Purity:
Min. 95%
Molecular weight:
839.05 g/mol
Ref: 3D-PVA81449
| 5mg | 316.00 € | ||
| 50mg | 1,182.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
